Kenta Kotani, Mio Matsumura, Yuji Morita, Junko Tomida, Ryo Kutsuna, Kunihiko Nishino, . . . Yoshiaki Kawamura. (2019). 13-(2-Methylbenzyl) Berberine Is a More Potent Inhibitor of MexXY-Dependent Aminoglycoside Resistance than Berberine. MDPI AG.
Chicago Style (17th ed.) CitationKenta Kotani, Mio Matsumura, Yuji Morita, Junko Tomida, Ryo Kutsuna, Kunihiko Nishino, Shuji Yasuike, and Yoshiaki Kawamura. 13-(2-Methylbenzyl) Berberine Is a More Potent Inhibitor of MexXY-Dependent Aminoglycoside Resistance than Berberine. MDPI AG, 2019.
MLA (9th ed.) CitationKenta Kotani, et al. 13-(2-Methylbenzyl) Berberine Is a More Potent Inhibitor of MexXY-Dependent Aminoglycoside Resistance than Berberine. MDPI AG, 2019.
Warning: These citations may not always be 100% accurate.